chr1-53210122-A-G

Variant summary

Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM1BP4

The NM_000098.3(CPT2):ā€‹c.448A>Gā€‹(p.Thr150Ala) variant causes a missense change. The variant allele was found at a frequency of 0.000431 in 1,613,944 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T150P) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.00020 ( 1 hom., cov: 32)
Exomes š‘“: 0.00046 ( 1 hom. )

Consequence

CPT2
NM_000098.3 missense

Scores

5
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:1

Conservation

PhyloP100: 5.01
Variant links:
Genes affected
CPT2 (HGNC:2330): (carnitine palmitoyltransferase 2) The protein encoded by this gene is a nuclear protein which is transported to the mitochondrial inner membrane. Together with carnitine palmitoyltransferase I, the encoded protein oxidizes long-chain fatty acids in the mitochondria. Defects in this gene are associated with mitochondrial long-chain fatty-acid (LCFA) oxidation disorders. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 1 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000098.3
BP4
Computational evidence support a benign effect (MetaRNN=0.27324116).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CPT2NM_000098.3 linkuse as main transcriptc.448A>G p.Thr150Ala missense_variant 4/5 ENST00000371486.4 NP_000089.1 P23786A0A140VK13
CPT2NM_001330589.2 linkuse as main transcriptc.448A>G p.Thr150Ala missense_variant 4/5 NP_001317518.1 A0A1B0GTB8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CPT2ENST00000371486.4 linkuse as main transcriptc.448A>G p.Thr150Ala missense_variant 4/51 NM_000098.3 ENSP00000360541.3 P23786

Frequencies

GnomAD3 genomes
AF:
0.000197
AC:
30
AN:
152086
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000242
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000412
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000155
AC:
39
AN:
251488
Hom.:
0
AF XY:
0.000147
AC XY:
20
AN XY:
135916
show subpopulations
Gnomad AFR exome
AF:
0.0000615
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000325
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000456
AC:
666
AN:
1461858
Hom.:
1
Cov.:
31
AF XY:
0.000414
AC XY:
301
AN XY:
727230
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000578
Gnomad4 OTH exome
AF:
0.000348
GnomAD4 genome
AF:
0.000197
AC:
30
AN:
152086
Hom.:
1
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74294
show subpopulations
Gnomad4 AFR
AF:
0.0000242
Gnomad4 AMR
AF:
0.0000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000412
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000131
Hom.:
0
Bravo
AF:
0.000136
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000132
AC:
16
EpiCase
AF:
0.000218
EpiControl
AF:
0.000296

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Carnitine palmitoyltransferase II deficiency Uncertain:2Benign:1
Uncertain significance, no assertion criteria providedclinical testingNatera, Inc.Jan 24, 2020- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Carnitine palmitoyl transferase II deficiency, severe infantile form Uncertain:2
Uncertain significance, no assertion criteria providedclinical testingKnight Diagnostic Laboratories, Oregon Health and Sciences UniversityDec 04, 2015- -
Uncertain significance, criteria provided, single submitterclinical testingBaylor GeneticsAug 03, 2018This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
not provided Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingRevvity Omics, RevvityMar 08, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJun 22, 2023- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.086
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.24
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.32
T;.;.;T;T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.011
FATHMM_MKL
Uncertain
0.88
D
LIST_S2
Uncertain
0.93
D;D;D;D;D
M_CAP
Benign
0.085
D
MetaRNN
Benign
0.27
T;T;T;T;T
MetaSVM
Benign
-0.34
T
MutationAssessor
Benign
0.68
N;.;.;.;.
PrimateAI
Benign
0.34
T
PROVEAN
Benign
-1.0
N;.;.;.;.
REVEL
Uncertain
0.31
Sift
Benign
0.046
D;.;.;.;.
Sift4G
Uncertain
0.052
T;.;.;.;.
Polyphen
0.20
B;.;.;.;.
Vest4
0.36
MVP
0.98
MPC
0.15
ClinPred
0.059
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.10
gMVP
0.34

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs141505320; hg19: chr1-53675794; COSMIC: COSV53760085; COSMIC: COSV53760085; API